Xoma | XOMA - Operating Profit

Stock Price
26.42
Daily Change
-0.03 -0.11%
Monthly
6.28%
Yearly
21.81%
Q1 Forecast
24.75

Xoma reported $-15.64M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Agenus USD -13.31M 12.58M Mar/2025
Agios Pharmaceuticals USD -121.58M 4.71M Dec/2025
Ardelyx USD 4.67M 19.07M Sep/2025
aTyr Pharma USD -26.74M 6.43M Sep/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Celldex Therapeutics USD -87.15M 13.54M Dec/2025
Curis USD -12.51M 40K Jun/2024
Eli Lilly USD 8.99B 599.9M Dec/2025
Emergent BioSolutions USD -218M 69.9M Jun/2023
Incyte USD 383.88M 47.43M Dec/2025
MacroGenics USD 18.64M 55.4M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Novartis USD 4.58B 879M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Prothena USD -39.76M 12.25M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Xoma USD -15.64M 5.56M Sep/2024